Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

FDA PMA

Transdermal test for Assessment of Glomerular Filtration Rate

Número do PMA: P230019 · 2026-06-10

RequerenteMedibeacon, Inc.
Data da decisão2026-06-10
Número PMAP230019
Código do produtoSDK
Classe do DispositivoClasse 3
Especialidade MédicaU
Comité consultivoGU

Resumo do dispositivo

Transdermal test for Assessment of Glomerular Filtration Rate is the device name listed in this FDA 510(k) record. The listed applicant is Medibeacon, Inc.. It received FDA 510(k) clearance on 2026-06-10. The device is classified under product code SDK. It was reviewed by the GU advisory panel.

Perguntas frequentes

What is the Transdermal test for Assessment of Glomerular Filtration Rate?

Transdermal test for Assessment of Glomerular Filtration Rate is a medical device that received FDA 510(k) clearance on 2026-06-10. The listed applicant is Medibeacon, Inc..

When did Transdermal test for Assessment of Glomerular Filtration Rate receive FDA 510(k) clearance?

The clearance date for Transdermal test for Assessment of Glomerular Filtration Rate can be found in the official FDA records.

Who is the listed applicant for Transdermal test for Assessment of Glomerular Filtration Rate?

The FDA 510(k) record lists Medibeacon, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Transdermal test for Assessment of Glomerular Filtration Rate?

The FDA product code for Transdermal test for Assessment of Glomerular Filtration Rate is SDK.

Ensaios clínicos relacionados

Registros relacionados são pareados automaticamente usando nomes, códigos de produtos ou outros metadados. Um pareamento não estabelece um vínculo clínico, científico, corporativo ou regulatório verificado; revise as fontes oficiais vinculadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fonte oficial

Ver na base de dados da FDA →

Dados provenientes da FDA Open API. Para informações mais recentes e oficiais, consulte sempre o registro oficial.

↑